Great Lakes Advisors, LLC Anavex Life Sciences Corp. Transaction History

Great Lakes Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$16.82 - $25.75 $11.4 Million - $17.5 Million	-679,703 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$10.16 - $28.86 $93,360 - $265,194	-9,189 Reduced 1.33%	679,703 $15.5 Million
Q1 2021 May 03, 2021	BUY	$5.17 - $16.13 $3.56 Million - $11.1 Million	688,892 New	688,892 $10.3 Million

163

27.5M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.